Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response

✍ Scribed by Lior Katz; Javier P. Gisbert; Beth Manoogian; Kirk Lin; Casper Steenholdt; Gerassimos J. Mantzaris; Ashish Atreja; Yulia Ron; Arun Swaminath; Somal Shah; Ailsa Hart; Peter Laszlo Lakatos; Pierre Ellul; Eran Israeli; Mads Naundrup Svendsen; C. Janneke van der Woude; Konstantinos H. Katsanos; Laura Yun; Epameinondas V. Tsianos; Torben Nathan; Maria Abreu; Iris Dotan; Bret Lashner; Jorn Brynskov′; Jonathan P. Terdiman; Peter D.R Higgins; Maria Chaparro; Shomron Ben-Horin

• Book ID: 112101294
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 903 KB
• Volume: 18
• Category: Article
• ISSN: 1078-0998
• DOI: 10.1002/ibd.22902